Literature DB >> 9485016

Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.

S Shibutani1, L Dasaradhi, I Terashima, E Banoglu, M W Duffel.   

Abstract

When alpha-hydroxytamoxifen (alpha-OHTAM) was incubated with rat liver hydroxysteroid (alcohol) sulfotransferase a (STa) and 3'-phosphoadenosine 5'-phosphosulfate, (E)-alpha-OHTAM was found to be a better substrate for STa than (Z)-alpha-OHTAM. To explore the formation of tamoxifen (TAM)-derived DNA adducts, DNA was incubated with STa and either (E)-alpha-OHTAM or (Z)-alpha-OHTAM in the presence of 3'-phosphoadenosine 5'-phosphosulfate. Using 32P-postlabeling analysis, the amount of TAM-DNA adducts resulting from (E)-alpha-OHTAM was 29 times higher than that observed with (E)-alpha-OHTAM alone. Using (Z)-alpha-OHTAM and STa, some TAM-DNA adducts were also detected but at levels 6.5 times lower than that observed with (E)-alpha-OHTAM and STa. When compared with standards of stereoisomers of 2'-deoxyguanosine 3'-monophosphate-N2-tamoxifen, the major tamoxifen adduct was identified chromatographically as an epimer of the trans form of alpha-(N2-deoxyguanosinyl)tamoxifen, and the minor adduct was identified as an epimer of the cis form. In the reaction mixture, a conversion from (E)-alpha-OHTAM to (Z)-alpha-OHTAM through the carbocation intermediate was also detected. These results show that sulfation of alpha-OHTAM catalyzed by STa results in the formation of TAM-DNA adducts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485016

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity.

Authors:  Janet K Coller; Niels Krebsfaenger; Kathrin Klein; Renzo Wolbold; Andreas Nüssler; Peter Neuhaus; Ulrich M Zanger; Michel Eichelbaum; Thomas E Mürdter
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).

Authors:  Edwin J Squirewell; Xiaoyan Qin; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

3.  Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics.

Authors:  Vineetha Koroth Edavana; Ishwori B Dhakal; Xinfeng Yu; Suzanne Williams; Susan Kadlubar
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

4.  Antiestrogens and the formation of DNA damage in rats: a comparison.

Authors:  Sung Yeon Kim; Naomi Suzuki; Y R Santosh Laxmi; Atsushi Umemoto; Tomonari Matsuda; Shinya Shibutani
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

5.  Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.

Authors:  Hong Liu; Zhihui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-07-13       Impact factor: 3.739

6.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01

7.  Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots.

Authors:  Evagelos Liapis; Keith I E McLuckie; Paul D Lewis; Peter B Farmer; Karen Brown
Journal:  Nucleic Acids Res       Date:  2008-09-19       Impact factor: 16.971

Review 8.  Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.

Authors:  Gabriel Tao; Junqing Huang; Bhagavatula Moorthy; Cathryn Wang; Ming Hu; Song Gao; Romi Ghose
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-09-02       Impact factor: 4.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.